CHEN Haichao, GUAN Hong. Clinical effect of amiodarone hydrochloride and potassium magnesium aspartate in the treatment of acute myocardial infarction patients complicating with malignant arrhythmia[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 70-72. DOI: 10.7619/jcmp.202012020
Citation: CHEN Haichao, GUAN Hong. Clinical effect of amiodarone hydrochloride and potassium magnesium aspartate in the treatment of acute myocardial infarction patients complicating with malignant arrhythmia[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 70-72. DOI: 10.7619/jcmp.202012020

Clinical effect of amiodarone hydrochloride and potassium magnesium aspartate in the treatment of acute myocardial infarction patients complicating with malignant arrhythmia

More Information
  • Received Date: February 25, 2020
  • Objective To investigate the effect of amiodarone hydrochloride and potassium magnesium aspartate in combination on efficacy and incidence of cardiogenic events in acute myocardial infarction patients complicating with malignant arrhythmia. Methods Seventy-eight acute myocardial infarction patients complicating with malignant arrhythmia were selected as research objects and were divided into control group and study group according to the random throwing method. The control group was treated with amiodarone hydrochloride on the basis of conventional treatment, while the study group was additionally treated with potassium magnesium aspartate on the basis of the control group. The clinical efficacy, cardiac function grading and cardiac function index before and after treatment, and the incidence of cardiogenic events in the two groups were compared. Results The total effective rate in the study group was 92.31%, which was significantly higher than 74.36%in the control group(P<0.05); there were no significant differences in the proportion of patients with grade Ⅱand Ⅳ of cardiac function after treatment between the two groups(P>0.05). The ratio of patients with grade Ⅰ of heart function was significantly higher, and ratio of patients with grade Ⅲof heart function was significantly lower than that in the control group(P<0.05). Before treatment, levels of cardiac stroke volume(SV), left ventricular ejection fraction(LVEF), cardiac troponin I(cTnI)in the two groups showed no significant differences(P>0.05); after treatment, levels of SV and LVEF in the study group were significantly higher than that in the control group, and cTnl level was significantly - lower than that in the control group(P<0.05); the incidence of cardiogenic events in the study group was 10.26%, which was lower than 28.21% of the control group(P<0.05). Conclusion Amiodarone hydrochloride and potassium magnesium aspartate in combination has significant effect in the treatment of acute myocardial infarction and malignant arrhythmia, which can improve the heart function and reduce the incidence of cardiogenic events.
  • 王尚华, 关亚东. 门冬氨酸钾镁联合酒石酸美托洛尔注射液与盐酸胺碘酮治疗急性心肌梗死合并心律失常临床观察[J]. 社区医学杂志, 2019, 17(23): 1522-1524

    , 1528.
    张文艳. 门冬氨酸钾镁联合胺碘酮治疗急性心肌梗死伴室性心律失常患者的临床效果[J]. 医疗装备, 2019, 32(18): 144-145.
    温宝平. 门冬氨酸钾镁联合美托洛尔、胺碘酮对心肌梗死合并心律失常患者的临床疗效[J]. 中国合理用药探索, 2019, 16(6): 153-156

    , 160.
    王林. 门冬氨酸钾镁联合胺碘酮治疗急性心肌梗死室性心律失常的临床疗效及其安全性[J]. 临床合理用药杂志, 2019, 12(12): 55-57.
    陈昭喆. 门冬氨酸钾镁联合胺碘酮对慢性心衰伴室性心律失常患者心电图指标的影响[J]. 西藏医药, 2019, 40(2): 46-47.
    陈超雄, 罗娜, 江健, 等. 胺碘酮联合美托洛尔和门冬氨酸钾镁治疗急性心肌梗死伴心律失常效果观察[J]. 临床合理用药杂志, 2019, 12(10): 56-57.
    王黎阳. 胺碘酮联合门冬氨酸钾镁对冠心病心律失常患者心电图及心功能的影响[J]. 中国卫生工程学, 2019, 18(1): 151-153.
    许真真. 门冬氨酸钾镁联合胺碘酮治疗急性心肌梗死伴室性心律失常临床疗效[J]. 大医生, 2019, 4(3): 120-122.
    周伟娟. 门冬氨酸钾镁联合胺碘酮治疗急性心肌梗死室性心律失常的效果观察[J]. 临床医学, 2019, 39(1): 120-122.
    吉寅, 姜金海, 高镇疆. 门冬氨酸钾镁联合胺碘酮治疗频发室性早搏的临床效果观察[J]. 中国处方药, 2019, 17(1): 102-103.
    颜蕾. 门冬氨酸钾镁治疗急性心肌梗死心律失常的效果[J]. 吉林医学, 2018, 39(12): 2298-2299.
    金艳勋. 门冬氨酸钾镁联合胺碘酮治疗急性心肌梗死室性心律失常的效果[J]. 名医, 2018(5): 139-139.
    晋辉, 郑海军, 王艳艳. 门冬氨酸钾镁联合胺碘酮治疗急性心肌梗死室性心律失常的疗效观察[J]. 现代诊断与治疗, 2018, 29(10): 1561-1563.
    贾爱玲. 门冬氨酸钾镁联合胺碘酮治疗急性心肌梗死伴室性心律失常的效果[J]. 河南医学研究, 2018, 27(7): 1250-1251.
    冯圣娇, 陈鹤. 门冬氨酸钾镁与胺碘酮联合治疗急性心肌梗死并发室性心律失常的疗效观察[J]. 中国医院用药评价与分析, 2018, 18(3): 354-355

    , 358.
    乔艳丽. 门冬氨酸钾镁联合胺碘酮对急性心肌梗死并发室性心律失常的疗效及安全性[J]. 中国卫生工程学, 2017, 16(4): 448-450.
    李春杰. 门冬氨酸钾镁联合胺碘酮治疗急性心肌梗死室性心律失常临床研究[J]. 中国药业, 2017, 26(10): 60-62.
    朱旭东. 急性心肌梗死心律失常患者门冬氨酸钾镁治疗的临床效果分析[J]. 系统医学, 2017, 2(2): 52-54.
  • Cited by

    Periodical cited type(1)

    1. 黄海芬,陈清勇,何芳,李韧. 高血压伴冠心病患者无创心输出量测量下个体化方案治疗的效果及机制. 实用临床医药杂志. 2025(05): 70-75+81 . 本站查看

    Other cited types(0)

Catalog

    Article views (395) PDF downloads (12) Cited by(1)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return